Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...
In an interview, outgoing FDA commissioner Robert Califf was wary of the Trump administration but unapologetic about ...
Rigel Pharmaceuticals on Thursday said the U.S. Food and Drug Administration granted orphan-drug designation to its proposed R289 treatment for myelodysplastic syndromes, a group of rare blood cancers ...
The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...
These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral ...
Protein powders may contain high levels of lead and cadmium, with chocolate-flavored and plant-based products testing at the ...
The Food and Drug Administration put guidelines in place to curb the amount of lead in baby food, but some like one Illinois ...
The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...
Red dye No. 3, used in drinks and snacks, could be banned by the U.S. Food and Drug Administration in the next few weeks, the ...
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.